Table 2.
Outcomes | Total (n=295) | Normocapnia (PaCO2=35–45 mm Hg) (n=57) |
Hypocapnia (PaCO2<35 mm Hg) (n=181) |
Hypercapnia (PaCO2>45 mm Hg (n=57) |
P Value |
Mortality | 41 (13.89%) | 2 (3.5%) | 28 (15.46%) | 11 (19.29%) | 0.35 |
Intubation | 56 (18.98%) | 9 (15.78%) | 35 (19.3%) | 12 (21.05%) | 0.37 |
NIMV use | 154 (52.20%) | 15 (26.31%) | 94 (51.93%) | 45 (78.94%) | 0.03 |
Overall LOS (mean), days |
7.3±5.0 | 9.0±5.2 | 6.24±3.5 | 9.27±7.57 | 0.009 |
LOS (mean) in survivors, days | 7.4±4.7 | 8.7±5.1 | 6.7±3.5 | 8.9±6.8 | 0.04 |
LOS in steroid users who survived, days |
6.3±4.4 | 6.0±3.5 | 5.86±2.9 | 7.57±7.0 | 0.49 |
TCS in steroid users, days | 3.0±1.8 | 1.89±0.6 | 2.66±1.5 | 4.43±2.1 | 0.001 |
LOS, length of hospital stay; NIMV, non-invasive mechanical ventilation; TCS, time to clinical stability.